Fig. 11

Comparison of drug sensitivity between different groups. (A) Two radiotherapy-associated biomarkers (cell cycle and hypoxia) were enriched in the high-risk group; (B) Comparison of drug sensitivity (5-Fu, Cisplatin, Docetaxel, and Paclitaxel) between various groups; (C) The drug sensitivity of targeted therapies between different groups